Cai et al. reported that metallothionein, as a potent antioxidant, prevented the development of diabetic cardiomyopathy through the inhibition of the mitochondrial cytochrome c-mediated caspase-3 activation pathway [75]. Here, CASP3 is linked to diabetic cardiomyopathy.